Mimpara Tablet 90mg (Cinacalcet Tablet) 90mg

MIMPARA TABLET 90MG contains Cinacalcet, a calcimimetic used to manage secondary hyperparathyroidism in adults with chronic kidney disease on dialysis. This 90mg strength tablet helps regulate calcium levels by signaling the parathyroid glands. Suitable for ambient storage, it supports patients requiring consistent parathyroid hormone management.

Strength

90mg

Pack Size

28s

Storage

Ambient

Manufacturer / TM Owner

Amgen BV

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Cinacalcet, the active ingredient in MIMPARA TABLET 90MG, is primarily used to treat secondary hyperparathyroidism in adults undergoing dialysis for chronic kidney disease. It works by lowering parathyroid hormone levels, calcium, and phosphorus in the blood, helping to reduce complications associated with overactive parathyroid glands. This medication is not a cure but supports long-term management of mineral imbalances.

Side Effects

MIMPARA TABLET 90MG helps restore balance to parathyroid hormone levels, which can alleviate symptoms like bone pain and muscle weakness. Patients may notice improved calcium and phosphorus regulation over time, contributing to overall comfort and reduced risk of complications. Individual responses vary, and effects depend on consistent use as directed.

Precautions & Warnings

Store MIMPARA TABLET 90MG at room temperature, away from moisture and direct light. Keep out of reach of children and pets. Inform your healthcare provider about all medications and conditions before starting this treatment. Regular blood tests may be required to monitor calcium and parathyroid hormone levels during use.

Avoid Interactions

MIMPARA TABLET 90MG may interact with other drugs that affect calcium or parathyroid hormone levels, such as vitamin D supplements or calcium-based phosphate binders. Caution is advised when combining with CYP3A4 inhibitors or inducers, as these can alter Cinacalcet’s effectiveness. Alcohol and grapefruit products may also influence its metabolism.

Frequently Asked Questions

MIMPARA TABLET 90MG is used to treat secondary hyperparathyroidism in adults with chronic kidney disease on dialysis.

Store MIMPARA TABLET 90MG at room temperature, away from moisture and direct light.

Consult a healthcare provider before combining MIMPARA TABLET 90MG with other drugs, especially vitamin D or calcium supplements.

Common side effects may include nausea, vomiting, or low calcium levels; report persistent issues to a doctor.

MIMPARA TABLET 90MG may not be suitable for individuals with certain conditions; discuss your medical history with a healthcare provider.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.